Historical record - last NADAC effective date: 3/18/2020
Product Information
NYSTATIN 100,000 UNIT/GM CREAM is a generic product labeled by Crown Laboratories, priced at $0.2999 per GM under NDC 00316022115. Its NADAC has been published 108 times since Mar 14, 2018.
FDA first approved this application on Sep 26, 2017. Its Orange Book therapeutic-equivalence code is AT.
Strength
100000 [USP'U]/g
Manufacturer
Crown LaboratoriesNDC
00316022115
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
3/18/2020
Active Ingredients
NYSTATINApproval Type
Generic (ANDA)
FDA Application
ANDA207733FDA Approved
9/26/2017
TE Code
AT
On Market Since
10/10/2017
Pharmacological Classes
Price Statistics
The NADAC for NYSTATIN 100,000 UNIT/GM CREAM has been published 108 times since Mar 14, 2018, and over the history we have for it it has declined 23.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2999 per GM |
|---|---|
| All-time high | $0.3907 (Mar 14, 2018) |
| All-time low | $0.2606 (Apr 17, 2019) |
| Median price | $0.2999 |
| Average price | $0.3052 |
| Largest weekly change | +16.5% (Feb 20, 2019) |
| Weeks tracked | 108 |
| Tracking since | Mar 14, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-23.3%
Last surveyed Apr 1, 2020 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 50% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Crown Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nystatin Cream market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Polyene Antifungal class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NYSTATIN 100,000 UNIT/GM CREAM?
The current National Average Drug Acquisition Cost (NADAC) for NYSTATIN 100,000 UNIT/GM CREAM, manufactured by Crown Laboratories, is $0.2999 per GM (NDC 00316022115), effective Apr 1, 2020.
How has the price of NYSTATIN 100,000 UNIT/GM CREAM changed over time?
Over the history we have for it, the NADAC for NYSTATIN 100,000 UNIT/GM CREAM has declined 23.3%. It has been tracked across 108 weekly CMS publications since Mar 14, 2018.
What are the highest and lowest recorded NADAC prices for NYSTATIN 100,000 UNIT/GM CREAM?
Since Mar 14, 2018, the NADAC for NYSTATIN 100,000 UNIT/GM CREAM has ranged from a low of $0.2606 (Apr 17, 2019) to a high of $0.3907 (Mar 14, 2018), with a median of $0.2999 per GM.
Are there cheaper alternatives to NYSTATIN 100,000 UNIT/GM CREAM?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NYSTATIN 100,000 UNIT/GM CREAM, is $0.1510 per GM — about 50% below NYSTATIN 100,000 UNIT/GM CREAM.
Who manufactures NYSTATIN 100,000 UNIT/GM CREAM?
NYSTATIN 100,000 UNIT/GM CREAM (NDC 00316022115) is labeled by Crown Laboratories, and CMS classifies it as a generic product.